Clinical and cost effectiveness of physiotherapy interventions following total hip replacement: a systematic review and meta-analysis by Fatoye, Francis et al.
Fatoye, Francis and Wright, JM and Yeowell, G and Gebrye, T (2020)Clin-
ical and cost effectiveness of physiotherapy interventions following total hip
replacement: a systematic review and meta-analysis. Rheumatology Inter-
national, 40. pp. 1385-1398.
Downloaded from: http://e-space.mmu.ac.uk/625680/
Version: Published Version
Publisher: Springer Verlag
DOI: https://doi.org/10.1007/s00296-020-04597-2
Usage rights: Creative Commons: Attribution 4.0
Please cite the published version
https://e-space.mmu.ac.uk
Vol.:(0123456789) 
Rheumatology International (2020) 40:1385–1398 
https://doi.org/10.1007/s00296-020-04597-2
SYSTEMATIC REVIEW
Clinical and cost‑effectiveness of physiotherapy interventions 
following total hip replacement: a systematic review 
and meta‑analysis
Francis Fatoye1  · J. M. Wright1  · G. Yeowell1  · T. Gebrye1 
Received: 20 February 2020 / Accepted: 4 May 2020 / Published online: 25 May 2020 
© The Author(s) 2020
Abstract
To examine the reported clinical and cost-effectiveness of physiotherapy interventions following total hip replacement (THR). 
A systematic review was completed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA). MEDLINE, CINAHL, AMED, Scopus, DARE, HTA, and NHS EED databases were searched for studies on 
clinical and cost-effectiveness of physiotherapy in adults with THR published up to March 2020. Studies meeting the inclu-
sion criteria were identified and key data were extracted. Risk of bias was assessed using the Cochrane Risk of Bias Tool and 
a Consolidated Health Economic Evaluation Reporting Standards (CHEERS). Data were summarised and combined using 
random-effect meta-analysis. A total of 1263 studies related to the aim of the review were identified, from which 20 studies 
met the inclusion criteria and were included in the review. These studies were conducted in Australia (n = 3), Brazil (n = 1), 
United States of America (USA) (n = 2), France (n = 2), Italy (n = 2), Germany (n = 3), Ireland (n = 1), Norway (n = 2), Canada 
(n = 1), Japan (n = 1), Denmark (n = 1), and United Kingdom (UK) (n = 1). The duration of follow-up of the included stud-
ies was ranged from 2 weeks to 12 months. Physiotherapy interventions were found to be clinically effective for functional 
performance, hip muscle strength, pain, and range of motion flexion. From the National Health Service perspective, an accel-
erated physiotherapy programme following THR was cost-effective. The findings of the review suggest that physiotherapy 
interventions were clinically effective for people with THR. However, questions remain on the pooled cost-effectiveness of 
physiotherapy interventions, and further research is required to examine this in patients with THR. Future studies are required 
to examine the cost-effectiveness of these interventions from patients, caregivers, and societal perspectives.
Registration Prospero (ID: CRD42018096524).
Keywords Cost-effectiveness · Physiotherapy · Total hip replacement · Systematic review
Introduction
Osteoarthritis (OA) is one of the major chronic diseases, and 
a primary cause of pain and disability among adults [1, 2]. 
Hip and knee OA ranked as the 11th highest contributor to 
global disability and 38th highest in disability-adjusted life 
years (DALYs) [3]. Between 1990 and 2010, the global age-
standardised prevalence of hip OA was 0.85% [95% uncer-
tainty interval (UI) 0.74–1.02%]. For people age ≥ 60 years, 
the prevalence of radiographic hip OA (7%) is less com-
mon than OA of the knee (37%) [4]. The prevalence of OA 
of the hip is higher in females than males [3]. Due to the 
severe long-term pain and disability resulting from OA hip, 
its clinical and economic impact is substantial. People with 
OA of the hip have difficulty with functional activities as 
well as high levels of depression and anxiety [5, 6]. The total 
costs of OA in the United States of America (USA), France, 
United Kingdom (UK), Canada, and Australia accounted for 
between 1 and 2.5% of the Gross National Product (GNP) for 
these countries [7]. In contrast, the cost of OA in Hong Kong 
accounted for 0.28% of the GNP which was between £253 
million and £308 million [7]. From this, the annual direct 
and indirect costs per person ranged from £384 to £883 and 
£261 to £525, respectively [8].
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Pharmaceutical management, non-pharmaceutical ther-
apies, and surgical procedures are advocated by clinical 
guidelines for managing OA of the hip [9]. Total hip replace-
ment (THR) is a common orthopaedic procedure for OA of 
the hip when conservative management fails [10]. Evidence 
showed that around 2.5 million (1.4 million women and 
1.1 million men) Americans are living with a THR [11]. 
Current clinical guidelines recommend that non-pharma-
ceutical therapies including access to appropriate informa-
tion to enhance understanding of the condition; activity and 
exercise; positive behavioural changes; manipulation and 
stretching; and transcutaneous electrical nerve simulation 
for patients following a THR for hip OA [12].
Previous systematic reviews have evaluated the effec-
tiveness of physiotherapy interventions following THR; 
however, they reported conflicting findings [13, 14]. Lowe 
et al. [13] indicated that physiotherapy exercise following 
THR has the potential to benefit patients. On the other hand, 
Wijnen et al. [14] identified that there was limited evidence 
to support the effectiveness of physiotherapy exercise fol-
lowing THR. Furthermore, there are no reviews that have 
been conducted on the cost-effectiveness of physiotherapy 
interventions following THR. Therefore, the purpose of 
this review was to investigate the clinical and cost-effec-
tiveness of physiotherapy interventions following THR, 
which could be used to inform clinical practice and patient 
decision-making.
Methods
Search protocol and registration
This systematic review used the Preferred Reporting Items 
for Systematic Reviews and Meta-Analysis (PRISMA), a 
technique that addresses the eligibility, data sources, selec-
tion of studies, data extraction, and data analysis as a report-
ing guideline [15]. This review was registered on PROS-
PERO, with registration number, CRD: CRD42018096524.
Data sources
A search of literature for published and unpublished studies 
was conducted to MEDLINE, Cumulative Index to Nursing 
and Allied Health Literature (CINAHL), AMED, Scopus, 
Database of Abstracts of Reviews of Effects (DARE), Health 
Technology Assessment (HTA) database, and the National 
Health Service Economic Evaluation Database (NHS EED) 
in the last 2 decades. The search terms used were hip, 
replace*, “total hip replacement’’, arthroplasty, “total hip 
arthroplasty’’, “therapeutic exercise’’, training, “functional 
training’’, “home physical training’’, “joint mobilization’’, 
exercise, physical therapist, therap*, treatment, medicine, 
muscle*, quadriceps*, strength, function, kinesiotherap*, 
rehabilitation, physiotherapy, “exercise therapy’’, “physical 
therapy’’, effectiveness, “clinical effectiveness’’, cost, value, 
money, expenditure, QALY, HRQoL, “healthcare costs’’, 
economics, “cost-effectiveness analysis’’, “cost-utility analy-
sis’’, and “cost–benefit analysis’’. These search terms were 
combined using conjunctions such as “AND’’ and “OR’’.
Search strategy
The Population, Intervention, Comparison, Outcome (PICO) 
framework was utilized in the development of the search 
strategy with search terms and limits relating to population 
of interest and intervention. The inclusion criteria were stud-
ies that: included patients (mean age ≥ 18 years) following 
THR for hip OA; assessed the clinical or cost-effectiveness 
of different forms of physiotherapy compared to other forms 
of physiotherapy or no intervention; reporting results of ran-
domized-controlled and retrospective/prospective trials. In 
this review, physiotherapy interventions covered a range of 
techniques including massage, passive stretching, functional 
rehabilitation, interdisciplinary rehabilitation, exercise, 
physical training, acupuncture, spinal manipulation, advice, 
yoga, cognitive behavioural therapy, and martial arts. The 
economic evaluation (cost-effectiveness analysis, cost–ben-
efit analysis, and cost–utility analysis) carried out alongside 
randomized-controlled trials and retrospective cohort study 
were included.
The outcomes of interest in this review included: pain, 
function, muscle strength, clinical and motor performance, 
activities of daily living, and health-related quality of life. 
To be included for the economic evaluation, studies had to 
relate the costs of the interventions to the effects of the inter-
ventions. Systematic reviews, narrative literature reviews, 
studies of non-English language, and conference papers were 
excluded. Further exclusion criteria were abstract unavail-
able, studies not yet fully completed, and studies carried out 
with THR patients mean aged < 18 years.
Duplicates were removed electronically and manually. 
Two independent researchers (TG and FF) were involved in 
screening the title and abstract of each study. Full-text arti-
cles were obtained and were excluded if they did not meet 
the inclusion criteria. Any disagreement in study selection 
was resolved through discussion and consultation with other 
members of the team (GY and JMW) where necessary.
Data extraction and risk of bias assessment
One of the researchers extracted data (TG) and the three 
members of the team cross-checked the extracted data (FF, 
GY, and JMW). The following data were extracted: author 
and date of the study, the location/country, type of partici-
pant, and the number of participants involved in the study. 
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The mean age, percentage of male and female participants 
who received the interventions and the control arm, and the 
type and the duration of the physiotherapy interventions 
were also extracted from each study. Furthermore, data 
regarding outcome measures, including the primary and 
secondary health outcomes, resource use and cost, and the 
cost-effectiveness ratio (ICER) were extracted.
Risk of bias for studies that met the inclusion criteria for 
the clinical effectiveness was assessed using the criteria of 
the Cochrane Risk of Bias Tool [16]. The Cochrane Col-
laboration’s tool aims to make the process clearer and more 
accurate, and it covers six domains of bias such as selection 
bias, performance bias, detection bias, attrition bias, report-
ing bias, and other bias. Studies were considered high risk 
of bias when one or more of the key domains had unclear or 
high risk of bias [16].
The Consolidated Health Economic Evaluation Reporting 
Standards (CHEERS) statement was also used as a reporting 
guideline for the included cost-effectiveness studies [17]. 
Twenty-four items were addressed in six categories, which 
include title and abstract, introduction, methods, results, dis-
cussion, and others. Cost-effectiveness studies were rated 
positive (√) if they reported in full, and negative (x) if they 
did not fulfil the listed criteria in the CHEERS statement. 
For those studies that have partial or inconclusive informa-
tion, they were labelled as partial (P). A total score of 1 was 
assigned if they fulfilled the requirement of reporting for 
that Item completely, 0 for not reporting and 0.5 for partial 
reporting. The maximum score for an article that reported 
completely all information was 24.
Data analysis
A descriptive synthesis and meta-analysis of the extracted 
data is presented. This study considered a weighting proce-
dure for the clinical effectiveness of physiotherapy interven-
tions as well as its cost-effectiveness of the included studies 
only when the procedure for combining data from multiple 
studies was satisfied. The continuous outcomes measures 
were expressed as a weighted mean difference with 95% 
confidence intervals. To summarise the findings across the 
studies, a statistical significance of p < 0.05 was set. Due to 
the statistical evidence of heterogeneity across the studies, 
a random-effects model was chosen [15].
Results
From the literature search, 1263 potentially relevant stud-
ies were identified. Of these, 181 duplicates were removed. 
The title and abstract of the remaining 1082 studies were 
screened for eligibility. The full texts of 44 remaining stud-
ies were reviewed. Overall, 20 studies were eligible and 
included in this review. A summary is provided in the sys-
tematic review flow diagram (Fig. 1).
Study characteristics
Eighteen studies assessed the clinical effectiveness of 
physiotherapy interventions and two studies examined cost-
effectiveness of the interventions using information from 
1400 and 108 patients following THR, respectively. The 
duration of follow-up of patients in the included studies 
ranged from 2 weeks to 12 months. The mean age of the 
participants in the intervention and control groups ranged 
from 46.93–68.6 years and 55.5–68.58 years, respectively. 
The geographical locations of these studies were: Australia 
(n = 3), Brazil (n = 1), USA (n = 2), France (n = 2), Italy 
(n = 2), Germany (n = 3), Ireland (n = 1), Norway (n = 2), 
Canada (n = 1), Japan (n = 1), Denmark (n = 1), and UK 
(n = 1) (Table 1).
Risk of bias
The assessment of risk of bias of the included clinical effec-
tiveness studies is presented in Table 2. All the included 
studies have unclear or high risk of bias within at least one 
domain, and thus, no studies have achieved a low risk of 
bias. Except two studies that were assigned high risk of bias 
[18] and unclear risk of bias [19] for reporting bias, most of 
the included studies achieved low risk of bias for the report-
ing and other bias. Thirteen and 16 out of 18 studies had 
high risk of bias for treatment allocation and blinding of 
participants of intervention. Sixteen out of eighteen studies 
had low risk of bias and two studies [20, 21] had unclear risk 
of bias for blinding outcome assessment. Five of eighteen 
studies were assigned unclear attrition bias, and the remain-
ing studies had low risk of bias.
In relation to the two included cost-effectiveness stud-
ies [22, 23], the CHEERS scores suggest that the methodo-
logical quality of the included studies had adequate quality 
(Table 4).
Effectiveness of physiotherapy interventions
The effectiveness of physiotherapy interventions was 
assessed in the included studies.
Acute hospital length of stay
Haas et al. [19] investigated the effect of an acute weekend 
physiotherapy service compared to no physiotherapy service 
following THR. Weekend physiotherapy service was associ-
ated with significantly increased odds of discharge directly 
home [odds ratio 3.151 (1.039–9.555)] and improved mobil-
ity [coefficient 4.301 (1.500–7.101)]. However, patients in 
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the intervention group perceived hospitalisation as less help-
ful and acute length of stay was longer compared to patients 
without physiotherapy services at the weekend. Overall, 
weekend physiotherapy service was beneficial on discharge 
destination and patient mobility.
Health‑related quality of life
Three studies reported the impact of physiotherapy interven-
tions on health-related quality of life (HRQoL) [21, 24, 25]. 
The Euroqol visual analogue scale [21, 24] and a self-admin-
istered HRQoL questionnaire [25] were used to assess the 
quality of life of THR patients. The comparative advantage 
of a targeted home- and centre-based exercise programme 
over unsupervised home-based exercise group were exam-
ined in patients following THR [25]. Patients who received 
the targeted home- and centre-based exercise programme 
achieved significant improvements (p < 0.05) in HRQoL. 
On the other hand, no clinically significant difference was 
observed between patients following THR in the groups who 
received inpatient and sports rehabilitation compared with 
control on HRQoL at 1 year [21, 24].
Function
The effects of physiotherapy interventions on functional 
performance in patients following THR were assessed in 
six studies [20, 26–30]. The findings of these studies dem-
onstrated that hydrotherapy, home exercise programme, 
physiotherapy-led functional exercise program, a 6-week 
arm exercise programme, an arm-interval exercise pro-
gram, in-hospital program based on task-oriented exer-
cises, and a targeted home and centre exercise programme 
were effective in improving the functional performance of 
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patients following THR. One of the studies [20] used Har-
ris Hip Score to measure function, whereas the remaining 
five studies [26–30] used Western Ontario and McMaster 
Universities (WOMAC) Osteoarthritis Index.
Muscle strength
Six studies investigated the effects of physiotherapy 
interventions on hip flexors muscle strength following 
THR [26, 31–35]. Compared to patients assigned into 
the control, improved hip muscle strength was observed 
in patients following THR who received home exercise 
programme, postoperative exercise programme, exercise 
programme focussing on hip external rotator muscle, 
supervised progressive resistance training, rehabilitation 
and muscle strength training.
Range of movement
Range of motion flexion data suitable for meta-analysis were 
available from two studies that compared physiotherapy 
and no physiotherapy interventions [20, 31]. As it is dem-
onstrated in Table 3, there was evidence that physiotherapy 
interventions significantly improved range of motion flexion 
with a standard difference in means 0.634 (95% CI 0.170, 
1.098, p = 0.007).
Pain
The effectiveness of physiotherapy on hip pain following 
THR was examined in seven studies conducted across dif-
ferent countries [20, 26, 27, 29–31, 33]. The findings of five 
of the studies [27, 29–31, 33] showed that hip pain was sig-
nificantly improved for those patients following THR in the 
Table 2  Summary of risk of bias assessment
+ 1, low risks of bias, − 1, high risk of bias, ?, unclear risk of bias
Random 
sequence gen-
eration (selection 
bias)
Allocation 
concealment 
(selection bias)
Blinding of 
participants and 
personnel (per-
formance bias)
Blinding of out-
come assessment 
(detection bias)
Incomplete 
outcome data 
(attrition bias)
Selective report-
ing (reporting 
bias)
Other bias
Umpierres et al. 
[31]
+ 1 + 1 − 1 + 1 + 1 + 1 + 1
Haas et al. [19] − 1 − 1 − 1 + 1 + 1 ? + 1
Naylor et al. [24] − 1 − 1 − 1 + 1 + 1 + 1 + 1
Trudelle-Jackson 
and Smith [36]
? − 1 1 + 1 ? + 1 + 1
Jan et al. [20] − 1 − 1 − 1 ? + 1 + 1 + 1
Husby et al. [37] + 1 − 1 − 1 + 1 ? + 1 + 1
Monaghan et al. 
[26]
+ 1 + 1 − 1 + 1 + 1 + 1 + 1
Okoro et al. [18] + 1 + 1 − + 1 ? − 1 + 1
Maire et al. [27] ? − 1 − 1 + 1 + 1 + 1 + 1
Beaupre et al. 
[32]
+ 1 − 1 1 + 1 + 1 + 1 + 1
Nankaku et al. 
[33]
+ 1 − 1 − 1 + 1 + 1 + 1 + 1
Maire et al. [28] + 1 − 1 − 1 + 1 + 1 + 1 + 1
Galea et al. [25] + 1 − 1 − 1 + 1 + 1 + 1 + 1
Giaquinto et al. 
[29]
? − 1 − 1 + 1 ? + 1 + 1
Monticone et al. 
[30]
+ 1 + 1 − 1 + 1 + 1 + 1 + 1
Mikkelsen et al. 
[34]
+ 1 + 1 − 1 + 1 + 1 + 1 + 1
Winther et al. 
[35]
? − 1 − 1 ? + 1 + 1 + 1
Beck et al. [21] ? − 1 − 1 + 1 ? + 1 + 1
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intervention group compared to control. Whereas two stud-
ies [26, 31] reported that patients following THR received 
home- and centre-based exercise and physiotherapy super-
vised functional exercise programme showed no significant 
improvement in hip pain.
Clinical and motor performance
One study [31] reported the effect of physiotherapy inter-
ventions on clinical and motor performance. The patients 
(n = 54) received rehabilitation assisted by the multidisci-
plinary hip group with the presence of physiotherapy pro-
fessionals. After the 15th postoperative day after discharge, 
those in the intervention groups showed greater improve-
ments in clinical (gait, pain, and mobility) and motor per-
formance (gait and pain) (p < 0.001) compared with those 
patients supported without physiotherapy professionals. 
Those in the intervention group have also showed signifi-
cantly greater improvements in muscle strength force (flex-
ion, p < 0.001; extension, p < 0.001; abduction, p = 0.003; 
internal rotation, p < 0.001; external rotation, p < 0.001) 
compared to the non-intervention group.
Cost‑effectiveness of physiotherapy interventions
Two of the included studies that compared accelerated physi-
otherapy with standard physiotherapy [22] and in-patient 
rehabilitation with out-patient physiotherapy [23] have 
conducted economic evaluation in patients of OA following 
THR (Table 4). The design of the studies was a cost–util-
ity analysis alongside randomized-controlled trial [22] and 
retrospective cohort study [23]. From the National Health 
Service (NHS) and healthcare insurer perspective, a £504 
per patient [22] and € 9,126.00 [23] costs were estimated 
for the accelerated physiotherapy and in-patient rehabilita-
tion, respectively. The incremental cost-effectiveness ratio 
estimate by Fusco et al. [22] and Krummenauer et al. [23] 
was £1,538/QALY and −€841/QALY gained, respectively. 
Overall, inpatient rehabilitation [23] was not cost-effective, 
whereas accelerated physiotherapy was associated with cost 
savings to the NHS of £200 per patient and additional 0.13 
QALY [22].
Discussion
This is the first systematic review and meta-analysis on clini-
cal and cost-effectiveness of physiotherapy interventions fol-
lowing THR. The search strategy identified 20 clinical and 
cost-effectiveness studies on physiotherapy interventions 
from Australia, Brazil, USA, France, Italy, Germany, Ire-
land, Norway, Canada, Japan, Denmark, and United King-
dom. The risk of bias in these studies was assessed using the 
Cochrane Risk of Bias Tool. All of the 18 studies included 
for the clinical effectiveness of physiotherapy interventions 
in the review had unclear or high risk of bias. The meth-
odological quality of the two cost-effectiveness studies was 
assessed as adequate.
In line with the findings a systematic review by Lowe 
et al. [13] on clinical effectiveness of physiotherapy exer-
cise following hip arthroplasty for osteoarthritis, the present 
study confirmed that physiotherapy interventions improved 
physical function, health-related quality of life, mobility, 
and muscle strength. In addition, the findings of our review 
showed that physiotherapy interventions improved self-per-
ceived function, postural stability, fast-walking speed, stair 
climbing, and discharge destination following THR. On the 
other hand, physiotherapy interventions did not reduce hos-
pital length of stay, fear of falling, hip pain, and function. 
Furthermore, compared to out-patient physiotherapy inter-
ventions, inpatient physiotherapy interventions following 
THR did not show a significantly superior cost-effectiveness 
from a healthcare insurer perspective.
Table 3  Forest plot of the mean 
difference I hip flexion for 
total hip replacement between 
physiotherapy and without 
physiotherapy
Cot control, Tx treatment, CI confidence interval
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The results of the meta-analysis of two studies [20, 31] 
also showed that physiotherapy intervention was benefi-
cial compared to a control, which contradicts the findings 
of Lowe and colleagues [13]. Their review which focussed 
specifically on an outcome measure of range of motion such 
as flexion, extension defect, and abduction that combined 
data from four studies showed that there were no statistically 
significant differences between groups for hip joint range of 
motion. One possible reason for the contradiction may be 
the characteristics of the physiotherapy interventions such 
as exercise, duration of follow-up, and the outcome measures 
used in the individual studies.
We have adopted a robust search strategy to locate and 
identify all potential studies that investigated the effec-
tiveness and cost-effectiveness of physiotherapy interven-
tions including exercise, massage, taping, kinesiology, 
rehabilitation, joint mobilisation, and sport. Four inde-
pendent reviewers have participated in the review process, 
and it has been possible to include all relevant literature 
in this study. Due to the fact that public health practition-
ers and policymakers are utilizing innovative and up-to-
date physiotherapy guidelines, this review has focused on 
studies carried out in the last 2 decades. Given the small 
number of studies included for this review, the clinical 
and cost-effectiveness of physiotherapy interventions 
should be interpreted with caution. The present review 
may have been affected by language bias. Consequently, 
a small number of studies published in languages other 
than English might have been excluded and it is difficult 
to generalize the clinical and cost-effectiveness of physi-
otherapy interventions based on the findings of this review.
Table 4  Summary of the characteristics of the studies reporting the clinical outcomes and cost-effectiveness for patients of THR
Int intervention, Cot control, WOMAC Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index
φ CHERS Quality score
Study/location/
study design/time-
horizon
Population Intervention Control Outcomes/meas-
urement used
Cost/perspective Results (Int vs Cot) /24φ
Fusco et al. 
[22]; UK/cost-
utility analy-
sis/12 months
#80 Accelerated physi-
otherapy re-edu-
cation to increase 
walking distance 
and direction and 
reduce reliance 
on aids
Standard physi-
otherapy
EuroQol EQ-5D Direct cost/
National Health 
Service
Cost
I n = £504 per 
patient
Cot = £705 per 
patient
Effectiveness
Int = 0.91 (0.03)
Cot = 0.73 (0.05)
Cost-effectiveness
Int. was cost-effec-
tive than Cot
22
Krummenauer 
et al. [23] 
Germany/cost-
effectiveness 
analysis/6 months
#28 In-patient physi-
otherapy
Out-patient physi-
otherapy
WOMAC score 
(%), utility, qual-
ity adjusted life 
years
Direct costs/health-
care insurer
Cost
Int = €9126.00; 
Cot = €8706.00
Effectiveness
Int = 38% before, 
and 87% after 
surgery (WOMC 
score)
Cot = 41% before, 
and 88% after 
surgery
Cost-effectiveness
Cost/effect = €420 
[198, 475]/0.77 
[95% CI − 2.13, 
3.18] QALYs
 = −€841/QALY 
(p = 0.791)
Inpatient reha-
bilitation was 
not cost-effective 
compared to out-
patient rehabilita-
tion
20
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Conclusion
This review indicates that following THR, patients with 
OA of the hip showed significant improvement in physical 
function, health-related quality of life, mobility, and muscle 
strength with physiotherapy interventions in a short term. On 
the other hand, physiotherapy interventions were not effec-
tive in terms of hospital length of stay, acute length of stay, 
fear of falling, and hip pain and function for patients follow-
ing THR. In relation to the findings of the cost-effectiveness 
of physiotherapy interventions in this review, it is difficult to 
reach a conclusion as they were based on a small number of 
studies. In addition, outcome measures used in future studies 
need to include those which measure (or reflect) the wider 
social determinants of health; for example, the perspectives 
of patients, their caregivers, and other societal perspectives.
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